Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets.
John CafferkeyJames Andrew CoultasPatrick MalliaPublished in: Expert review of respiratory medicine (2020)
Respiratory virus infections are the trigger of a substantial proportion of COPD exacerbations and rhinoviruses are the most common virus type. Clinical trials of anti-viral agents are needed in COPD patients to determine whether they are effective in virus-induced COPD exacerbations.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- clinical trial
- cystic fibrosis
- endothelial cells
- end stage renal disease
- ejection fraction
- newly diagnosed
- sars cov
- randomized controlled trial
- high glucose
- prognostic factors
- risk assessment
- disease virus
- climate change
- patient reported outcomes
- human health
- air pollution